Table 1.
Metabolite | Producer | Antibiotic affected | Mechanism | Refs |
---|---|---|---|---|
PYO | Pseudomonas aeruginosa | Fluoroquinolones, aminoglycosides*, chloramphenicol, carbenicillin | Efflux induction, oxidative stress response induction | 36,44,45 |
PCA, PCN | P. aeruginosa | Ciprofloxacin, tobramycin, carbenicillin | Metabolic changes | 44 |
Paerucumarin | P. aeruginosa | Chloramphenicol, ciprofloxacin | Efflux induction | 50 |
Indole | Escherichia coli | Fluoroquinolones, gentamicin, ampicillin, carbenicillin | Efflux induction, oxidative stress response induction | 27,31,77,111 |
Salicylate | Burkholderia spp. | Chloramphenicol, trimethoprim, ciprofloxacin | Efflux induction | 55 |
HQNO | P. aeruginosa | Meropenem | Increased extracellular DNA release and biofilm formation | 153 |
Ergothioneine | Mycobacterium tuberculosis | Rifampicin, isoniazid, bedaquiline, clofazimine | Direct ROS detoxification, redox buffering | 89 |
Polyamines (putrescine, spermidine) | E. coli, Burkholderia cenocepacia, P. aeruginosa | Levofloxacin, amikacin, cefotaxime, polymyxin B, norfloxacin, rifampicin, tobramycin | Direct ROS detoxification, decreased drug penetration | 99,101 |
PQS | P. aeruginosa | Ciprofloxacin, oxofloxacin, imipenem, meropenem, gentamicin, colistin | Increased ROS generation | 103,105 |
H2S | Diverse microorganisms | Gentamicin, amikacin, nalidixic acid, ciprofloxacin, ampicillin | Oxidative stress response induction, Fe2+ sequestration, redox buffering | 97,154 |
Staphyloxanthin | Staphylococcus aureus | ND | Direct ROS detoxification | 90,91 |
Carotenoids | Streptococcus spp. | ND | Direct ROS detoxification | 92,93 |
2,3-dihydroxybenzoate | E. coli | ND | Efflux induction | 25 |
Toxoflavin | Burkholderia spp. | ND | Efflux induction**, oxidative stress response induction** | 65,68 |
Phthiocol | M. tuberculosis | ND | Oxidative stress response induction** | 155,156 |
D-alanylgriseoluteic acid | Pantoea agglomerans | ND | Oxidative stress response induction** | 157,158 |
β−3H-indolydenopyruvate | Achromobacter sp. | ND | ND | 159 |
Anthraquinones (for example, emodin, endocrocin) | Aspergillus spp. | ND | ND | 160,161 |
HQNO, 2-n-heptyl-4-hydroxyquinoline N oxide; PCA, phenazine 1-carboxylic acid; PCN, phenazine 1-carboxamide; PQS, Pseudomonas quinolone signal; PYO, pyocyanin, ROS, reactive oxygen species.
ND, not determined; these are molecules whose effects on antibiotics have not been directly tested.
For aminoglycosides, PYO has been shown to increase or decrease antibiotic resilience, depending on the studied conditions.
Hypothesized mechanisms by which the molecule might affect susceptibility.